

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.11013076 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.56737590 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.56737590 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 7.41558351 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.23835001 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.23835001 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 7.01210016 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.93768288 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.42774072 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.42774072 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.42774072 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.25615327 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.23055333 |
| 14 | tryptophan metabolic process (GO:0006568) | 6.01665461 |
| 15 | bile acid biosynthetic process (GO:0006699) | 6.00870310 |
| 16 | regulation of plasminogen activation (GO:0010755) | 5.90166400 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.73679584 |
| 18 | complement activation, alternative pathway (GO:0006957) | 5.72782896 |
| 19 | regulation of protein activation cascade (GO:2000257) | 5.72130004 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.66946786 |
| 21 | urea cycle (GO:0000050) | 5.66655945 |
| 22 | urea metabolic process (GO:0019627) | 5.66655945 |
| 23 | drug metabolic process (GO:0017144) | 5.58661754 |
| 24 | protein carboxylation (GO:0018214) | 5.55205444 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.55205444 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 5.54932374 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.52201551 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 5.40851407 |
| 29 | oxidative demethylation (GO:0070989) | 5.35503064 |
| 30 | regulation of complement activation (GO:0030449) | 5.32781641 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.20293476 |
| 32 | cysteine metabolic process (GO:0006534) | 5.14522186 |
| 33 | sulfur amino acid catabolic process (GO:0000098) | 5.14396591 |
| 34 | phenylpropanoid metabolic process (GO:0009698) | 5.12656749 |
| 35 | bile acid metabolic process (GO:0008206) | 5.11311519 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 5.04673856 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 5.02799742 |
| 38 | ethanol metabolic process (GO:0006067) | 4.95979829 |
| 39 | negative regulation of blood coagulation (GO:0030195) | 4.95838161 |
| 40 | negative regulation of hemostasis (GO:1900047) | 4.95838161 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.90093455 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.86715666 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.86605954 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.83696176 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.78835955 |
| 46 | regulation of humoral immune response (GO:0002920) | 4.73995441 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.73361399 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.73361399 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 4.73361399 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.65642536 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.65642536 |
| 52 | homocysteine metabolic process (GO:0050667) | 4.63242601 |
| 53 | phospholipid efflux (GO:0033700) | 4.62668964 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.62538963 |
| 55 | coenzyme catabolic process (GO:0009109) | 4.55860359 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 4.53869932 |
| 57 | lysine catabolic process (GO:0006554) | 4.53782245 |
| 58 | lysine metabolic process (GO:0006553) | 4.53782245 |
| 59 | negative regulation of coagulation (GO:0050819) | 4.52126040 |
| 60 | amino-acid betaine metabolic process (GO:0006577) | 4.51750058 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 4.51336898 |
| 62 | negative regulation of sterol transport (GO:0032372) | 4.51336898 |
| 63 | amine catabolic process (GO:0009310) | 4.49024120 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 4.49024120 |
| 65 | negative regulation of wound healing (GO:0061045) | 4.48530553 |
| 66 | bile acid and bile salt transport (GO:0015721) | 4.42352492 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.36333193 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.30884208 |
| 69 | positive regulation of hemostasis (GO:1900048) | 4.30675266 |
| 70 | positive regulation of blood coagulation (GO:0030194) | 4.30675266 |
| 71 | glycine metabolic process (GO:0006544) | 4.29746487 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 4.27501714 |
| 73 | cellular glucuronidation (GO:0052695) | 4.26453510 |
| 74 | cellular amino acid catabolic process (GO:0009063) | 4.22365465 |
| 75 | cholesterol efflux (GO:0033344) | 4.21938872 |
| 76 | benzene-containing compound metabolic process (GO:0042537) | 4.17684296 |
| 77 | glutamate metabolic process (GO:0006536) | 4.17275615 |
| 78 | intestinal cholesterol absorption (GO:0030299) | 4.13291284 |
| 79 | fibrinolysis (GO:0042730) | 4.10498170 |
| 80 | S-adenosylmethionine metabolic process (GO:0046500) | 4.09302194 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 4.08525913 |
| 82 | complement activation, classical pathway (GO:0006958) | 4.06578503 |
| 83 | arginine metabolic process (GO:0006525) | 4.04077831 |
| 84 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.01315990 |
| 85 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00264976 |
| 86 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.99665449 |
| 87 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.99665449 |
| 88 | ethanol oxidation (GO:0006069) | 3.99503470 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 3.98531296 |
| 90 | cytolysis (GO:0019835) | 3.98513575 |
| 91 | complement activation (GO:0006956) | 3.97183408 |
| 92 | positive regulation of coagulation (GO:0050820) | 3.95970645 |
| 93 | negative regulation of complement activation (GO:0045916) | 3.95915345 |
| 94 | blood coagulation, intrinsic pathway (GO:0007597) | 3.93269916 |
| 95 | protein activation cascade (GO:0072376) | 3.93121696 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 3.92853169 |
| 97 | drug catabolic process (GO:0042737) | 3.90689577 |
| 98 | low-density lipoprotein particle remodeling (GO:0034374) | 3.90065684 |
| 99 | alkaloid metabolic process (GO:0009820) | 3.89366384 |
| 100 | serine family amino acid biosynthetic process (GO:0009070) | 3.88373291 |
| 101 | aldehyde catabolic process (GO:0046185) | 3.88326077 |
| 102 | cofactor catabolic process (GO:0051187) | 3.87322875 |
| 103 | negative regulation of lipase activity (GO:0060192) | 3.81454163 |
| 104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.81209540 |
| 105 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.81209540 |
| 106 | * acute inflammatory response (GO:0002526) | 3.79386753 |
| 107 | glucuronate metabolic process (GO:0019585) | 3.78223546 |
| 108 | uronic acid metabolic process (GO:0006063) | 3.78223546 |
| 109 | opsonization (GO:0008228) | 3.77969874 |
| 110 | regulation of bile acid biosynthetic process (GO:0070857) | 3.77828040 |
| 111 | flavonoid metabolic process (GO:0009812) | 3.77644085 |
| 112 | hormone catabolic process (GO:0042447) | 3.76501804 |
| 113 | negative regulation of protein activation cascade (GO:2000258) | 3.73937031 |
| 114 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73816568 |
| 115 | NAD biosynthetic process (GO:0009435) | 3.73086127 |
| 116 | ketone body metabolic process (GO:1902224) | 3.72306344 |
| 117 | plasma lipoprotein particle organization (GO:0071827) | 3.72036095 |
| 118 | positive regulation of lipid catabolic process (GO:0050996) | 3.69091342 |
| 119 | phospholipid homeostasis (GO:0055091) | 3.68934331 |
| 120 | cholesterol homeostasis (GO:0042632) | 3.68710616 |
| 121 | * acute-phase response (GO:0006953) | 3.68198836 |
| 122 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.67562221 |
| 123 | carboxylic acid catabolic process (GO:0046395) | 3.66751421 |
| 124 | organic acid catabolic process (GO:0016054) | 3.66751421 |
| 125 | daunorubicin metabolic process (GO:0044597) | 3.65447326 |
| 126 | polyketide metabolic process (GO:0030638) | 3.65447326 |
| 127 | doxorubicin metabolic process (GO:0044598) | 3.65447326 |
| 128 | regulation of cholesterol homeostasis (GO:2000188) | 3.63988954 |
| 129 | sterol homeostasis (GO:0055092) | 3.63033934 |
| 130 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.61637675 |
| 131 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.61637675 |
| 132 | regulation of lipoprotein particle clearance (GO:0010984) | 3.60791962 |
| 133 | regulation of apoptotic cell clearance (GO:2000425) | 3.55191532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.31678412 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.17370389 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.12369156 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.45024081 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.32399591 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.05917239 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.59776190 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.12135095 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.07837731 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01217896 |
| 11 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8577284 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.87638204 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81279506 |
| 14 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.60993933 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60392189 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.59121036 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.53366882 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38983227 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38573216 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37189583 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33578233 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26301781 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23400392 |
| 24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20150597 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18271816 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03941109 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01861857 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.99577763 |
| 29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99465171 |
| 30 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.92208998 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85440688 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84912991 |
| 33 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83441335 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83291638 |
| 35 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80781546 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78898165 |
| 37 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76503313 |
| 38 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.76306097 |
| 39 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.74226551 |
| 40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74020549 |
| 41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.74007479 |
| 42 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73635519 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72706192 |
| 44 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70587031 |
| 45 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67448908 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.67217927 |
| 47 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67136416 |
| 48 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.67005891 |
| 49 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66537514 |
| 50 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66537514 |
| 51 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.66195120 |
| 52 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65817317 |
| 53 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.65713158 |
| 54 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.65429195 |
| 55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.63511807 |
| 56 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62666275 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.62072021 |
| 58 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62029968 |
| 59 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.61803096 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.61598673 |
| 61 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.61285823 |
| 62 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61098310 |
| 63 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.60909159 |
| 64 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.60715406 |
| 65 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.60103759 |
| 66 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59563207 |
| 67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.59355428 |
| 68 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.59024600 |
| 69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.57254412 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.56683327 |
| 71 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.56181524 |
| 72 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.55916226 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55284347 |
| 74 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54778949 |
| 75 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.54433676 |
| 76 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54369472 |
| 77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.52982534 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.52621666 |
| 79 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.52514081 |
| 80 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52320664 |
| 81 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.52083604 |
| 82 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.51961887 |
| 83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.51533321 |
| 84 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.51405735 |
| 85 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.51341814 |
| 86 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51324069 |
| 87 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51087157 |
| 88 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.51051829 |
| 89 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.51048349 |
| 90 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.50994108 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.50878710 |
| 92 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50731394 |
| 93 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50592687 |
| 94 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.50183641 |
| 95 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49700896 |
| 96 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49673778 |
| 97 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.49393892 |
| 98 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.48584382 |
| 99 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.48392669 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.48146240 |
| 101 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.47622008 |
| 102 | SA1_27219007_Chip-Seq_Bcells_Human | 0.47554048 |
| 103 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47482604 |
| 104 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.47258292 |
| 105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.47224198 |
| 106 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.44991088 |
| 107 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.44936394 |
| 108 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43328380 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.42828437 |
| 110 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42710995 |
| 111 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42475793 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.42318986 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.42261731 |
| 114 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.41583939 |
| 115 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40993267 |
| 116 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.40052704 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39831184 |
| 118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39643916 |
| 119 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.39373444 |
| 120 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.38847536 |
| 121 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.38769986 |
| 122 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.38335256 |
| 123 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.38289417 |
| 124 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.37456176 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37377156 |
| 126 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.36958704 |
| 127 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.36909647 |
| 128 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.36746407 |
| 129 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.36095256 |
| 130 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.35035879 |
| 131 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.35033731 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.34944123 |
| 133 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34776909 |
| 134 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.34619883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.31743303 |
| 2 | MP0005360_urolithiasis | 7.50770259 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.53124318 |
| 4 | MP0005365_abnormal_bile_salt | 6.20369559 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.08841757 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.21432593 |
| 7 | MP0003252_abnormal_bile_duct | 3.92737614 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.59756752 |
| 9 | MP0009840_abnormal_foam_cell | 3.21676049 |
| 10 | MP0005083_abnormal_biliary_tract | 3.04074552 |
| 11 | MP0003195_calcinosis | 2.81854320 |
| 12 | MP0005332_abnormal_amino_acid | 2.71065454 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.58761410 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.49389146 |
| 15 | MP0000609_abnormal_liver_physiology | 2.15653111 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.11671784 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09841996 |
| 18 | MP0003868_abnormal_feces_composition | 1.97703811 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.93931618 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82886390 |
| 21 | MP0009697_abnormal_copulation | 1.74224226 |
| 22 | MP0001764_abnormal_homeostasis | 1.66462616 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53173998 |
| 24 | MP0003011_delayed_dark_adaptation | 1.37110850 |
| 25 | MP0005451_abnormal_body_composition | 1.35380693 |
| 26 | MP0005647_abnormal_sex_gland | 1.27467850 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.22306969 |
| 28 | MP0003186_abnormal_redox_activity | 1.20834701 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.19223034 |
| 30 | MP0000598_abnormal_liver_morphology | 1.15604600 |
| 31 | MP0009764_decreased_sensitivity_to | 1.14911840 |
| 32 | MP0009763_increased_sensitivity_to | 1.05561230 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.04520386 |
| 34 | MP0002254_reproductive_system_inflammat | 1.03408859 |
| 35 | MP0000604_amyloidosis | 1.02774090 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.02435149 |
| 37 | MP0001915_intracranial_hemorrhage | 1.00048272 |
| 38 | MP0005670_abnormal_white_adipose | 0.98491237 |
| 39 | MP0008469_abnormal_protein_level | 0.93519833 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 0.92243653 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.87910570 |
| 42 | MP0002876_abnormal_thyroid_physiology | 0.84056955 |
| 43 | MP0005408_hypopigmentation | 0.81986970 |
| 44 | MP0009765_abnormal_xenobiotic_induced | 0.78381185 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 0.76764580 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.76712994 |
| 47 | MP0003879_abnormal_hair_cell | 0.76143899 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 0.75640327 |
| 49 | MP0005220_abnormal_exocrine_pancreas | 0.75246398 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 0.72311271 |
| 51 | MP0002971_abnormal_brown_adipose | 0.70638233 |
| 52 | MP0005334_abnormal_fat_pad | 0.70244049 |
| 53 | MP0003690_abnormal_glial_cell | 0.69007755 |
| 54 | MP0002282_abnormal_trachea_morphology | 0.67062980 |
| 55 | MP0005535_abnormal_body_temperature | 0.66401906 |
| 56 | MP0005187_abnormal_penis_morphology | 0.65713345 |
| 57 | MP0009053_abnormal_anal_canal | 0.64575981 |
| 58 | MP0005058_abnormal_lysosome_morphology | 0.62627249 |
| 59 | MP0004130_abnormal_muscle_cell | 0.61904799 |
| 60 | MP0001661_extended_life_span | 0.61703876 |
| 61 | MP0000639_abnormal_adrenal_gland | 0.61536026 |
| 62 | MP0005464_abnormal_platelet_physiology | 0.59754726 |
| 63 | MP0005266_abnormal_metabolism | 0.59346569 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 0.54349529 |
| 65 | MP0002249_abnormal_larynx_morphology | 0.54319530 |
| 66 | MP0005023_abnormal_wound_healing | 0.54027576 |
| 67 | MP0003724_increased_susceptibility_to | 0.52771133 |
| 68 | MP0005448_abnormal_energy_balance | 0.52151235 |
| 69 | MP0001756_abnormal_urination | 0.52038182 |
| 70 | MP0009785_altered_susceptibility_to | 0.51508345 |
| 71 | MP0000566_synostosis | 0.51342713 |
| 72 | MP0004381_abnormal_hair_follicle | 0.50172431 |
| 73 | MP0002089_abnormal_postnatal_growth/wei | 0.49778412 |
| 74 | MP0005395_other_phenotype | 0.49692785 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 0.49239732 |
| 76 | MP0002928_abnormal_bile_duct | 0.49184728 |
| 77 | MP0003436_decreased_susceptibility_to | 0.48951710 |
| 78 | MP0002822_catalepsy | 0.47992845 |
| 79 | MP0003329_amyloid_beta_deposits | 0.47637010 |
| 80 | MP0005248_abnormal_Harderian_gland | 0.46105511 |
| 81 | MP0003718_maternal_effect | 0.45993790 |
| 82 | MP0008874_decreased_physiological_sensi | 0.45303249 |
| 83 | MP0005166_decreased_susceptibility_to | 0.45214828 |
| 84 | MP0003638_abnormal_response/metabolism_ | 0.44927541 |
| 85 | MP0002136_abnormal_kidney_physiology | 0.43422733 |
| 86 | MP0002132_abnormal_respiratory_system | 0.42235719 |
| 87 | MP0000579_abnormal_nail_morphology | 0.42121789 |
| 88 | MP0003075_altered_response_to | 0.40511078 |
| 89 | MP0008873_increased_physiological_sensi | 0.40374962 |
| 90 | MP0003953_abnormal_hormone_level | 0.40219416 |
| 91 | MP0006082_CNS_inflammation | 0.38145434 |
| 92 | MP0005666_abnormal_adipose_tissue | 0.37313841 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.35007466 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.34865277 |
| 95 | MP0008872_abnormal_physiological_respon | 0.33926071 |
| 96 | MP0009115_abnormal_fat_cell | 0.33338057 |
| 97 | MP0001881_abnormal_mammary_gland | 0.31977043 |
| 98 | MP0009672_abnormal_birth_weight | 0.31053598 |
| 99 | MP0000249_abnormal_blood_vessel | 0.30611114 |
| 100 | MP0002168_other_aberrant_phenotype | 0.30284688 |
| 101 | MP0002837_dystrophic_cardiac_calcinosis | 0.30247939 |
| 102 | MP0004883_abnormal_blood_vessel | 0.30097841 |
| 103 | MP0001845_abnormal_inflammatory_respons | 0.29918984 |
| 104 | MP0001853_heart_inflammation | 0.29541853 |
| 105 | MP0002970_abnormal_white_adipose | 0.28400320 |
| 106 | MP0000230_abnormal_systemic_arterial | 0.28102880 |
| 107 | MP0002796_impaired_skin_barrier | 0.28046183 |
| 108 | MP0000427_abnormal_hair_cycle | 0.27958646 |
| 109 | MP0000467_abnormal_esophagus_morphology | 0.26499734 |
| 110 | MP0001243_abnormal_dermal_layer | 0.26476338 |
| 111 | MP0005164_abnormal_response_to | 0.24678913 |
| 112 | MP0002060_abnormal_skin_morphology | 0.24291419 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.22539074 |
| 114 | MP0002090_abnormal_vision | 0.20627275 |
| 115 | MP0000920_abnormal_myelination | 0.20587897 |
| 116 | MP0005197_abnormal_uvea_morphology | 0.18274824 |
| 117 | MP0003959_abnormal_lean_body | 0.18220499 |
| 118 | MP0004272_abnormal_basement_membrane | 0.17469914 |
| 119 | MP0003878_abnormal_ear_physiology | 0.17135255 |
| 120 | MP0005377_hearing/vestibular/ear_phenot | 0.17135255 |
| 121 | MP0002128_abnormal_blood_circulation | 0.16708816 |
| 122 | MP0003632_abnormal_nervous_system | 0.16252153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.47469433 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.37086675 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.34438241 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.83095503 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.66685040 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.27879028 |
| 7 | Xanthomatosis (HP:0000991) | 6.15358665 |
| 8 | Complement deficiency (HP:0004431) | 5.98224707 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.61784544 |
| 10 | Joint hemorrhage (HP:0005261) | 5.01943360 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.74909756 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.72073051 |
| 13 | Hyperammonemia (HP:0001987) | 4.52524009 |
| 14 | Epidermoid cyst (HP:0200040) | 4.45068884 |
| 15 | Hyperglycinemia (HP:0002154) | 4.44960408 |
| 16 | Abnormality of complement system (HP:0005339) | 4.36421209 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.32209640 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.19897186 |
| 19 | Fat malabsorption (HP:0002630) | 4.19775973 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 4.19570276 |
| 21 | Ketosis (HP:0001946) | 4.18070648 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.17514608 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.11023989 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.04573044 |
| 25 | Conjugated hyperbilirubinemia (HP:0002908) | 3.93089721 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.91142796 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.89481194 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.82941476 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.82941476 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.79274902 |
| 31 | Hyperglycinuria (HP:0003108) | 3.78403710 |
| 32 | Spontaneous abortion (HP:0005268) | 3.55651080 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.52643214 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.27349339 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.25750948 |
| 36 | Steatorrhea (HP:0002570) | 3.24789491 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.24264869 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 3.09497653 |
| 39 | Hypochromic microcytic anemia (HP:0004840) | 3.08070389 |
| 40 | Myocardial infarction (HP:0001658) | 3.06253873 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05559563 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.04191042 |
| 43 | Delayed CNS myelination (HP:0002188) | 3.02120994 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.93682145 |
| 45 | Ketoacidosis (HP:0001993) | 2.90351445 |
| 46 | Purpura (HP:0000979) | 2.85431331 |
| 47 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.78404665 |
| 48 | Metabolic acidosis (HP:0001942) | 2.71595589 |
| 49 | Skin nodule (HP:0200036) | 2.68133379 |
| 50 | Vascular calcification (HP:0004934) | 2.64236299 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.63598748 |
| 52 | Hypoglycemic seizures (HP:0002173) | 2.59915078 |
| 53 | Glomerulonephritis (HP:0000099) | 2.57174220 |
| 54 | Mitral stenosis (HP:0001718) | 2.56245493 |
| 55 | Gingival bleeding (HP:0000225) | 2.55151098 |
| 56 | Osteomalacia (HP:0002749) | 2.52726258 |
| 57 | Reduced antithrombin III activity (HP:0001976) | 2.52495481 |
| 58 | Lethargy (HP:0001254) | 2.51570712 |
| 59 | Amyloidosis (HP:0011034) | 2.46172931 |
| 60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.45642270 |
| 61 | Dicarboxylic aciduria (HP:0003215) | 2.45642270 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 2.37509051 |
| 63 | Spastic diplegia (HP:0001264) | 2.36910656 |
| 64 | Acanthocytosis (HP:0001927) | 2.35972511 |
| 65 | Gout (HP:0001997) | 2.33645837 |
| 66 | Cholelithiasis (HP:0001081) | 2.33145492 |
| 67 | Cardiovascular calcification (HP:0011915) | 2.33087369 |
| 68 | Neonatal onset (HP:0003623) | 2.32887238 |
| 69 | Cerebral edema (HP:0002181) | 2.28416545 |
| 70 | Cholecystitis (HP:0001082) | 2.27128377 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 2.27128377 |
| 72 | Irritability (HP:0000737) | 2.26157898 |
| 73 | Thrombophlebitis (HP:0004418) | 2.25561085 |
| 74 | Menorrhagia (HP:0000132) | 2.25199128 |
| 75 | Enlarged kidneys (HP:0000105) | 2.17819859 |
| 76 | Arthropathy (HP:0003040) | 2.17042011 |
| 77 | Malnutrition (HP:0004395) | 2.15554598 |
| 78 | Sensorimotor neuropathy (HP:0007141) | 2.14646779 |
| 79 | Late onset (HP:0003584) | 2.14432876 |
| 80 | Esophageal varix (HP:0002040) | 2.13856094 |
| 81 | Pancreatitis (HP:0001733) | 2.13257965 |
| 82 | Opisthotonus (HP:0002179) | 2.12473875 |
| 83 | Abnormality of the Achilles tendon (HP:0005109) | 2.12437163 |
| 84 | Fair hair (HP:0002286) | 2.09975103 |
| 85 | Brushfield spots (HP:0001088) | 2.09861419 |
| 86 | Hemorrhage of the eye (HP:0011885) | 2.05529259 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02501604 |
| 88 | Neonatal hypoglycemia (HP:0001998) | 2.02176722 |
| 89 | Vomiting (HP:0002013) | 2.00162959 |
| 90 | Hyperphosphaturia (HP:0003109) | 1.99254517 |
| 91 | Generalized aminoaciduria (HP:0002909) | 1.97129403 |
| 92 | Renal cortical cysts (HP:0000803) | 1.94772311 |
| 93 | Hypophosphatemic rickets (HP:0004912) | 1.93814105 |
| 94 | Rickets (HP:0002748) | 1.93524795 |
| 95 | Abnormality of the gallbladder (HP:0005264) | 1.93388459 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 1.93310026 |
| 97 | Poikilocytosis (HP:0004447) | 1.91686790 |
| 98 | Gangrene (HP:0100758) | 1.91108428 |
| 99 | Bifid scrotum (HP:0000048) | 1.90235545 |
| 100 | Increased serum ferritin (HP:0003281) | 1.90215901 |
| 101 | Hydroxyprolinuria (HP:0003080) | 1.90086116 |
| 102 | Abnormality of proline metabolism (HP:0010907) | 1.90086116 |
| 103 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88943308 |
| 104 | Joint swelling (HP:0001386) | 1.88359132 |
| 105 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84065051 |
| 106 | Status epilepticus (HP:0002133) | 1.83565233 |
| 107 | Elevated hepatic transaminases (HP:0002910) | 1.83468606 |
| 108 | Hyperglycemia (HP:0003074) | 1.80721345 |
| 109 | Nephritis (HP:0000123) | 1.80506799 |
| 110 | Glycosuria (HP:0003076) | 1.79688412 |
| 111 | Abnormality of urine glucose concentration (HP:0011016) | 1.79688412 |
| 112 | Elevated alkaline phosphatase (HP:0003155) | 1.76706118 |
| 113 | Abnormality of vitamin metabolism (HP:0100508) | 1.76450019 |
| 114 | Alkalosis (HP:0001948) | 1.75983009 |
| 115 | Epistaxis (HP:0000421) | 1.73460874 |
| 116 | Increased serum pyruvate (HP:0003542) | 1.72183102 |
| 117 | Pulmonary embolism (HP:0002204) | 1.72017233 |
| 118 | Abnormal cartilage morphology (HP:0002763) | 1.70568208 |
| 119 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.65630835 |
| 120 | Abnormal urine phosphate concentration (HP:0012599) | 1.61606560 |
| 121 | Abnormal delivery (HP:0001787) | 1.59785508 |
| 122 | Potter facies (HP:0002009) | 1.52715450 |
| 123 | Facial shape deformation (HP:0011334) | 1.52715450 |
| 124 | Atrioventricular block (HP:0001678) | 1.52711980 |
| 125 | Impaired platelet aggregation (HP:0003540) | 1.51139800 |
| 126 | Abnormal platelet function (HP:0011869) | 1.51139800 |
| 127 | Abnormal tarsal ossification (HP:0008369) | 1.50223962 |
| 128 | Increased mean platelet volume (HP:0011877) | 1.47723585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.63588751 |
| 2 | ERN1 | 4.78251439 |
| 3 | FGFR4 | 4.69317318 |
| 4 | SIK1 | 4.62282645 |
| 5 | TAOK3 | 3.26728710 |
| 6 | INSRR | 3.26503744 |
| 7 | ERBB4 | 3.25995774 |
| 8 | MAP2K4 | 2.37985744 |
| 9 | MAPK11 | 2.02762008 |
| 10 | LATS1 | 1.89102983 |
| 11 | MST1R | 1.88286609 |
| 12 | PIK3CG | 1.83117049 |
| 13 | TYK2 | 1.72740586 |
| 14 | FLT3 | 1.61596517 |
| 15 | PKN2 | 1.55237161 |
| 16 | NTRK3 | 1.53656108 |
| 17 | NEK9 | 1.51850164 |
| 18 | DAPK2 | 1.41691679 |
| 19 | PRPF4B | 1.37528882 |
| 20 | MAP3K14 | 1.36584664 |
| 21 | TRIB3 | 1.34372974 |
| 22 | FRK | 1.33918258 |
| 23 | ABL2 | 1.33801745 |
| 24 | PTK6 | 1.31448794 |
| 25 | JAK2 | 1.22370198 |
| 26 | FGFR2 | 1.21381809 |
| 27 | MAP3K2 | 1.19423134 |
| 28 | MAP3K7 | 1.16018212 |
| 29 | PRKAA2 | 1.13744913 |
| 30 | KDR | 1.13310142 |
| 31 | STK38L | 1.12238161 |
| 32 | ERBB2 | 1.11829579 |
| 33 | JAK1 | 1.11552400 |
| 34 | PINK1 | 1.09708461 |
| 35 | TBK1 | 1.08637536 |
| 36 | MAP2K3 | 1.07432631 |
| 37 | EPHA3 | 1.07297407 |
| 38 | TIE1 | 1.05935065 |
| 39 | MAPK15 | 1.05551821 |
| 40 | MAP3K12 | 0.99435766 |
| 41 | MAPK4 | 0.95548550 |
| 42 | PDK1 | 0.93155148 |
| 43 | PRKCZ | 0.91533792 |
| 44 | GRK6 | 0.88319470 |
| 45 | EPHB1 | 0.88202568 |
| 46 | CDK12 | 0.84691973 |
| 47 | MAPK12 | 0.82857519 |
| 48 | PRKG1 | 0.82855911 |
| 49 | IRAK3 | 0.82682697 |
| 50 | PDGFRA | 0.81989408 |
| 51 | MAPKAPK3 | 0.80641080 |
| 52 | EIF2AK1 | 0.80289528 |
| 53 | MAP3K3 | 0.78540919 |
| 54 | MAP2K6 | 0.75730903 |
| 55 | MAP3K11 | 0.74006421 |
| 56 | CAMK2G | 0.73832817 |
| 57 | SGK3 | 0.73321152 |
| 58 | IKBKE | 0.71696395 |
| 59 | PRKACG | 0.70873911 |
| 60 | CDK6 | 0.70722808 |
| 61 | MAPK7 | 0.70587584 |
| 62 | SGK2 | 0.70153591 |
| 63 | MYLK | 0.67274415 |
| 64 | TGFBR2 | 0.66501025 |
| 65 | TNK2 | 0.66324314 |
| 66 | CAMK1D | 0.66022620 |
| 67 | FGFR3 | 0.65896442 |
| 68 | CSK | 0.65599321 |
| 69 | FER | 0.65398880 |
| 70 | PRKACA | 0.65045825 |
| 71 | SIK3 | 0.64758203 |
| 72 | TAOK2 | 0.64338362 |
| 73 | FGFR1 | 0.63768311 |
| 74 | CSNK1D | 0.63277012 |
| 75 | PRKAA1 | 0.62294643 |
| 76 | PKN1 | 0.61604518 |
| 77 | MET | 0.61241954 |
| 78 | MAP3K10 | 0.59972100 |
| 79 | SGK1 | 0.59843144 |
| 80 | MAP3K13 | 0.59067072 |
| 81 | GSK3A | 0.58385157 |
| 82 | DYRK1B | 0.58096730 |
| 83 | ZAP70 | 0.55555323 |
| 84 | SCYL2 | 0.55010847 |
| 85 | KSR2 | 0.54868271 |
| 86 | GRK1 | 0.53847505 |
| 87 | CSNK1E | 0.53725488 |
| 88 | RPS6KA3 | 0.51577466 |
| 89 | MAP3K5 | 0.51502368 |
| 90 | WNK4 | 0.50926690 |
| 91 | PRKCB | 0.50856403 |
| 92 | CSF1R | 0.49470610 |
| 93 | PRKCQ | 0.49030116 |
| 94 | EPHA4 | 0.48784050 |
| 95 | IRAK1 | 0.48605891 |
| 96 | CAMKK2 | 0.48485794 |
| 97 | ARAF | 0.47841788 |
| 98 | SRC | 0.44619735 |
| 99 | IGF1R | 0.44356934 |
| 100 | CSNK2A2 | 0.44197442 |
| 101 | CAMKK1 | 0.43257390 |
| 102 | CSNK2A1 | 0.42294578 |
| 103 | PDPK1 | 0.42285700 |
| 104 | CAMK4 | 0.42234202 |
| 105 | MAP3K6 | 0.41664549 |
| 106 | SGK494 | 0.41312457 |
| 107 | SGK223 | 0.41312457 |
| 108 | CSNK1G1 | 0.40708416 |
| 109 | STK16 | 0.40622245 |
| 110 | PRKACB | 0.39160082 |
| 111 | PRKCG | 0.38743522 |
| 112 | RIPK1 | 0.38356177 |
| 113 | AKT3 | 0.37923611 |
| 114 | CDK7 | 0.37049146 |
| 115 | PTK2 | 0.36523674 |
| 116 | CDK4 | 0.34061432 |
| 117 | IRAK2 | 0.34015255 |
| 118 | MAP2K1 | 0.33649791 |
| 119 | SIK2 | 0.33427283 |
| 120 | PIK3CA | 0.32897594 |
| 121 | EGFR | 0.32046820 |
| 122 | MAPK3 | 0.29532308 |
| 123 | PDK2 | 0.28947004 |
| 124 | PBK | 0.28729663 |
| 125 | MTOR | 0.27871256 |
| 126 | RET | 0.27107427 |
| 127 | ICK | 0.26455611 |
| 128 | MAP3K1 | 0.26155617 |
| 129 | KIT | 0.26066147 |
| 130 | PRKCA | 0.25834874 |
| 131 | LATS2 | 0.25799318 |
| 132 | CAMK1G | 0.22805623 |
| 133 | CHUK | 0.22759515 |
| 134 | ABL1 | 0.22465777 |
| 135 | NLK | 0.21101795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.67872598 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.42363483 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39214549 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31010869 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08352508 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.99194163 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72086125 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61945408 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57762862 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55060124 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44105443 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33952700 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24922589 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12652189 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.10639637 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10495077 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.01781149 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94905128 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92114132 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91419936 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90842501 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86072549 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84828936 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79340008 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78885028 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73630738 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71512752 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71052400 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70511060 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.69660362 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57159688 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55404116 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54133624 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53954040 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.48296311 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46847808 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43104346 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30231537 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29784889 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28422388 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27867060 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25895336 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25194296 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.22677382 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16099680 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14249287 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13345481 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.10452001 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10089700 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04072062 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98310260 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97808748 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97671859 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97357648 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95170467 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94060815 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86373176 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.81095629 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78799014 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75651500 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65026177 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63924080 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60706150 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51065093 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51051698 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.49167154 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47244319 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45252715 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.32010800 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.25871086 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25430834 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23362832 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.23172638 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22273373 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22122940 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20187102 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16122601 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13102671 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09074495 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.06585288 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2728374 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2690720 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2444315 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2392834 |
| 85 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2247037 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2225509 |
| 87 | Pertussis_Homo sapiens_hsa05133 | -0.2181626 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | -0.2124298 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2095219 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2024366 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2012737 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1753465 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1486524 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1439365 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1354691 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1330591 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1223714 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1138581 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1104250 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0951862 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0896908 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0874537 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0822656 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0698615 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0651711 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0384664 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0366819 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0025240 |

